Chelation therapy.
This statement was prepared in response to a request made to the Clinical Pharmacology Service at the University of California, San Francisco to evaluate the potential therapeutic uses and the possible toxicities of chelation therapy. The question arose in regard to the use of ethylene tetraacetic acid (EDTA) in the treatment of atherosclerotic cardiovascular disease.
D002114:Calcinosis / Q000188:drug therapy; D002118:Calcium; D002614:Chelating Agents / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D006801:Humans
D002614:Chelating Agents; D002118:Calcium